Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 12Recruiting 4Unknown 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Venous Thromboembolism 1Multiple Myeloma 1

Interventions

hetrombopag 2treosulfan 1fludarabine 1ferric carboxymaltose 1Vancomycin 1Therapeutics 1Teicoplanin 1Surgical Procedures, Operative 1S-Adenosylmethionine 1Rosuvastatin Calcium 1Rivaroxaban 1Ofloxacin 1Observation 1NF protocol 1Metronidazole 1Meropenem 1Melphalan 1Levofloxacin 1Lead 1Honey 1Heparin, Low-Molecular-Weight 1Dalteparin 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Blood Specimen Collection 1Aspirin 1Amikacin 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Rivaroxaban × Classical hematology × Clear all
NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡